SCHEMBL272341

SCHEMBL272341

CCCCCCCCCCCCCCCc1cccs1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.57
TSHR P16473 1/20 0.50
MEN1 O00255 1/20 0.46
GAPDH P04406 1/20 0.46
POLB P06746 1/20 0.46
ALOX15 P16050 1/20 0.46
NR4A1 P22736 1/20 0.46
APEX1 P27695 1/20 0.46
PTPN7 P35236 1/20 0.46
BLM P54132 1/20 0.46
KMT2A Q03164 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CTDSP1 Q9GZU7 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
NPC1 O15118 2/20 0.44
MAPT P10636 2/20 0.44
ALDH1A1 P00352 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2734233 1.00 TAAR1 (0.57) TAAR1TSHRMEN1GAPDHPOLB
SCHEMBL271943 1.00 TAAR1 (0.57) TAAR1TSHRMEN1GAPDHPOLB
SCHEMBL2734280 1.00 TAAR1 (0.57) TAAR1TSHRMEN1GAPDHPOLB
SCHEMBL272288 1.00 TAAR1 (0.57) TAAR1TSHRMEN1GAPDHPOLB
SCHEMBL2734409 1.00 TAAR1 (0.57) TAAR1TSHRMEN1GAPDHPOLB
SCHEMBL271561 1.00 TAAR1 (0.57) TAAR1TSHRMEN1GAPDHPOLB
SCHEMBL23407 1.00 TAAR1 (0.57) TAAR1TSHRMEN1GAPDHPOLB
SCHEMBL270626 1.00 TAAR1 (0.57) TAAR1TSHRMEN1GAPDHPOLB
SCHEMBL271466 1.00 TAAR1 (0.57) TAAR1TSHRMEN1GAPDHPOLB
SCHEMBL25851 1.00 TAAR1 (0.57) TAAR1TSHRMEN1GAPDHPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117334560-A Improved self-assembled monolayer blocking with intermittent air-water exposure 应用材料公司 2024-01-02 CN claimed
CN-109075021-B Improved self-assembled monolayer blocking with intermittent air-water exposure 应用材料公司 2023-09-05 CN claimed
CN-104370937-B The synthetic method and purposes of a kind of containing oxygen group elements and five condensed ring conjugated molecules and its derivative 浙江华显光电科技有限公司 2018-04-10 CN claimed
CN-104370937-A Oxygen family element-containing penta-condensed ring conjugated molecule and its derivative synthetic method and purpose thereof ZHEJIANG OUPU PHOTOELECTRIC TECHNOLOGY CO LTD 2015-02-25 CN claimed
CN-102906307-A Method for protecting silver and silver alloy surfaces against tarnishing MESA S A S DI MALIMPENSA SIMONA E DAVIDE E C 2013-01-30 CN claimed
CN-118198340-A Composite carbon material, preparation method thereof, negative plate and secondary battery 江西欣荣锂电材料有限公司 2024-06-14 CN disclosed
CN-111032606-B Bisphenol composition and method for producing same, and polycarbonate resin and method for producing same 三菱化学株式会社 2024-01-30 CN disclosed
CN-117304927-A Preparation method of small-size zirconium disulfide quantum dot 中国科学院上海光学精密机械研究所 2023-12-29 CN disclosed
US-11833129-B2 Thiophene compound for treatment of exfoliating glaucoma AVOSCIENCE, LLC (US) 2023-12-05 US disclosed
US-11833129-B2 Thiophene compound for treatment of exfoliating glaucoma AVOSCIENCE, LLC (US) 2023-12-05 US disclosed
CN-110419093-B Treatment method for improving film roughness by improving nucleation/adhesion of silicon oxide 应用材料公司 2023-12-01 CN disclosed
US-11796939-B2 Conveying device and image forming apparatus FUJIFILM BUSINESS INNOVATION CORP. (JP) 2023-10-24 US disclosed
US-20080089836-A1 superparamagnetic nanoparticles of iron coated with bilayer of molecules:(a) layer of oleic acid in direct contact with the iron particles; (b) a layer of Tween\"; bilayer of surface binding molecules and amphiphatic molecules; self-assembles; solubilizing; reducing toxicity; gold in MRI and tomography NANOPROBES, INC. (US) 2008-04-17 US disclosed
WO-2007041570-A1 DEVICES AND METHODS FOR ANALYTE DETECTION USING DISTORTED LIQUID CRYSTALS WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2007-04-12 WO disclosed
EP-1748805-A1 ABSORBABLE BIOCOMPATIBLE MATERIALS Biointeractions Ltd. (GB) 2007-02-07 EP disclosed
US-20060134166-A1 Absorbable biocompatible materials BIOINTERACTIONS LTD. (GB) 2006-06-22 US disclosed
WO-2005115492-A1 ABSORBABLE BIOCOMPATIBLE MATERIALS BIOINTERACTIONS LTD (GB) 2005-12-08 WO disclosed
US-6602594-B2 Mixture of a granular or powdery heat-fusible substance and a granular or powdery dyestuff that can be diffused through dispersion or dissolution; indicators; microcapsules NICHIYU GIKEN KOGYO CO., LTD. (JP) 2003-08-05 US disclosed
US-20010044014-A1 Irreversible heat-sensitive composition NICHIYU GIKEN KOGYO CO., LTD. 2001-11-22 US disclosed
EP-1149880-A1 Irreversible heat-sensitive composition Nichiyu Giken Kogyo Co., Ltd. (JP) 2001-10-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060134166-A1 Absorbable biocompatible materials ADM2, HDGF, SLC7A1 TAAR1 631/4885TSHR 2905/4885MEN1 1091/4885
US-20080089836-A1 superparamagnetic nanoparticles of iron coated with bilayer of molecules:(a) layer of oleic acid in direct contact with the iron particles; (b) a layer of Tween\"; bilayer of surface binding molecules and amphiphatic molecules; self-assembles; solubilizing; reducing toxicity; gold in MRI and tomography TFRC, FABP1, SCARB1 TAAR1 1013/4885TSHR 1345/4885MEN1 1197/4885
US-11833129-B2 Thiophene compound for treatment of exfoliating glaucoma TYMP, TDP1, TDP2 TAAR1 1835/4885TSHR 2439/4885MEN1 1722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.